MOPEAD has the potential to contribute to move the AD Environment towards earlier diagnosis to improve identification of appropriate patients for disease modifying therapies.

The MOPEAD project is designed to assess different Patient Engagement models across Europe, to identify efficient approaches of earlier identification of mild AD dementia and prodromal AD patients.

MOPEAD aims to deliver a step-change in AD patient engagement strategies and a paradigm shift from late-stage diagnosis to early-stage diagnosis. It will strive to improve the identification of subjects with mild cognitive impairment at an early stage.

The project will assess key tools, mechanisms and processes for community engagement, patient identification and resource utilisation. Multiple regional project sites will be established to identify and test models (Runs) of efficient early identification of mild AD dementia and prodromal AD patients. The project will be conducted in Germany, Sweden, Slovenia, Spain and The Netherlands.